News & Events

Toft Group Completes Search for Senior Vice President, Commercial Operations for Novoheart (TSXV: NVH; FWB: 3NH)

Executive search firm Toft Group has placed Bill Williams, PhD as Senior Vice President, Commercial Operations for Novoheart (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company.

Dr. Williams has over 20 years of experience in the life science industry spanning business development, sales and marketing. He was most recently Vice President, Global Sales, Marketing and Business Development with Organovo, Inc. He joined Organovo from Aushon Biosystems where he spent 3 years as their Vice President, Global Sales and Marketing. Earlier in his industry career, Dr. Williams held management roles for Ciphergen Biosystems and Beckman Coulter.

Dr. Williams holds a PhD in Analytical Chemistry from Texas A&M University.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Novoheart

Novoheart is a global stem cell biotechnology company pioneering an array of next-generation human heart tissue prototypes. It is the first company in the world to have engineered miniature living human heart pumps that can revolutionize drug discovery, helping to save time and money for developing new therapeutics.  Also known as ‘human heart-in-a-jar’, Novoheart’s bio-artificial human heart constructs are created using state-of-the-art and proprietary stem cell and bioengineering approaches and are utilized by drug developers for accurate preclinical testing as to the effectiveness and safety of new drugs, maximizing the successes in drug discovery whilst minimizing costs and harm caused to patients.

Toft Group Completes Search for Vice President, Global Customer Operations for Luminex Corporation (Nasdaq:LMNX) in Austin, TX

Executive search firm Toft Group has placed W. Ryan Snellings as Vice President of Global Customer Operations for Luminex Corporation (Nasdaq:LMNX) in Austin, TX.

Mr. Snellings was most recently the Vice President of Operations at Fresenius Kabi, a leading global health care company. He has over 15 years’ experience in service operations and logistics and spent several years working in Europe leading the service team that supports Europe, Middle East, and Africa. Earlier in his industry career, Mr. Snellings served with Baxter Healthcare. Mr. Snellings holds an MBA from the Keller Graduate School of Management and a BS in Information Studies from Florida State University.

About Luminex Corporation

Luminex Corporation offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

Toft Group Completes Search for Manager of Medical Affairs for QOL Medical, LLC. in Vero Beach, FL

Executive search firm Toft Group has placed Lauren Remkus, PharmD, as Manager of Medical Affairs for QOL Medical, LLC. in Vero Beach, FL.

Dr. Remkus was previously Senior Medical Science Liaison at Shire Pharmaceuticals. She joined Shire in May 2013 as Manager, Medical Communications, Global Medical Affairs. Dr. Remkus also served as a Fellow at Janssen Research and Development with responsibility for safety evaluations including review of clinical and post – marketing adverse event case reports. She also authored post-marketing safety documents including periodic safety update report (PSUR) and ad hoc reports written to identify potential adverse drug reactions.
Dr. Remkus holds a PharmD from Touro College of Pharmacy in New York.

About QOL Medical

QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underserved markets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.